Castren & Snellman advised Pohjola Bank plc in the financing of a transaction in which Vaaka Partners, a Finnish private equity firm, acquired a majority of the shares in the Kh-kiinteistöpalvelut group.

The Kh-kiinteistöpalvelut group provides property management and related services for housing companies in the Helsinki Metropolitan Area.

The financing arrangements were successfully carried out by the C&S team led by partner Sakari Lukinmaa and supported by senior associate Antti Rintakoski and associates Kalle Maijala and Riikka Mustonen.

The shareholders' meeting of nextevolution Aktiengesellschaft, Hamburg, has adopted by a large majority the transfer of the shares held by the minority shareholders to the main shareholder Heidelberg Capital Private Equity Fund II GmbH & Co. KG against payment of an adequate cash consideration in the amount of EUR 6.23 per share (squeeze-out).

Swedish private equity investor EQT has purchased the EIS Aircraft Group. The E.I.S. Group consists of the E.I.S. Holding GmbH, E.I.S. Aircraft GmbH and the DEVA-Plastics Technology GmbH. The sellers consisted of a group of private investors. The purchase price was not disclosed.

The E.I.S. Aircraft Group is a provider of products and services to civil and military aviation. The company develops and produces cabin interiors for commercial aircraft and provides in addition aircraft maintenance and repair services. Customers include, inter alia, Airbus and Boeing.

Davis Polk advised Tencent Holdings Limited in connection with its acquisition of a controlling stake in a new holding company of Miniclip Group SA. The financial terms of the transaction have not been disclosed.

Davis Polk is advising Greenhill as lead financial adviser to Ball Corporation on its £4.3 billion takeover of Rexam plc, to be effected by means of a scheme of arrangement. Under the terms of the offer, which is subject to both an antitrust pre-condition and customary offer conditions, Rexam shareholders will receive a mixture of cash and new shares in Ball Corporation. Following completion of the transaction, Rexam shareholders are expected to hold approximately 19% of the combined group.

DBA Lab SpA, an ICT company engaged in the development of software platforms in support of engineering, project and asset management, safety and control of industrial automation, that is part of the DBA Group (owned by its founding partners and by Fondo Italiano d’Investimento SGR SpA) concluded agreements for the acquisition of the entire capital of ACTUAL IT, a Slovenian company based in Koper and active in the development of IT solutions.
 

Gide advises Hitachi Data Systems Corporation (HDS), a wholly owned subsidiary of Japanese group Hitachi Ltd based in California, on the acquisition of oXya, a leader in SAP technical solutions, and cloud services.

The acquisition of oXya is expected to close by the end of March, subject to authorisation from the anti-trust authority. Upon the close of the acquisition, oXya will become a wholly owned subsidiary of Hitachi Data Systems and will continue to execute its current business model.

EQT acquired E.I.S. Aircraft Group on 13 February 2015 from a group of private shareholders. E.I.S. Aircraft Group designs and produces cabin interior components for commercial aircrafts and provides in addition to line and base maintenance of aircrafts flight simulation and training services for international customers. E.I.S. Aircraft Group comprises E.I.S. Holding GmbH, E.I.S. Aircraft GmbH and DEVA- Kunststofftechnik GmbH.

Slaughter and May is advising Towry Holdings Limited (Towry) on the recommended acquisition by one of its wholly owned subsidiaries of Ashcourt Rowan plc (Ashcourt Rowan) by way of a scheme of arrangement. The acquisition was announced on 2 February 2015.

Ashcourt Rowan shareholders will receive consideration per share comprising 270 pence in cash plus 5 pence principal amount of loan notes. The cash consideration values Ashcourt Rowan at approximately £97 million.

Pfizer Inc. announced that it has acquired a controlling interest in REDVAX GmbH, a spin-off from Redbiotec AG, a privately held Swiss biopharmaceutical company, based in Zurich-Schlieren. REDVAX GmbH is a preclinical stage company. The company develops multi-component virus-like particles (VLPs) and other protein assemblies for vaccine development in the field of cytomegalovirus (CMV) and a further undisclosed field. This transaction provides Pfizer Inc.